News Express: Ministry of Education Frontiers Science Center for Precision Oncology of UM holds its first Academic Committee meeting, academicians and scholars at home and abroad recognise its achievements

新聞快訊:國家教育部澳大精準腫瘤學前沿科學中心首屆學術委員會會議召開 成果獲海內外院士專家肯定


 

國家教育部澳大精準腫瘤學前沿科學中心首屆學術委員會會議召開
The first Academic Committee meeting of the Ministry of Education Frontiers Science Center for Precision Oncology of UM

 


國家教育部澳大精準腫瘤學前沿科學中心首屆學術委員會會議召開 成果獲海內外院士專家肯定

國家教育部澳門大學精準腫瘤學前沿科學中心舉辦首屆學術委員會會議,多名來自中國科學院、中國工程院、美國國家科學院等的海內外院士及科研專家聽取了報告並作出指導。此外,在與澳大校長宋永華會面期間,學術委員會委員高度肯定前沿科學中心的傑出成果,指中心的癌症研究在短短兩年多內的突破進展及紮實的研究質量令人矚目。

會議以線上線下結合的方式在澳大舉行,學術委員會委員聽取了中心自2020年12月獲批成立以來的平台建設、運行管理情況、成果產出質量、人才隊伍培養等方面的彙報。委員包括諾貝爾得獎者阿龍·切哈諾沃教授、盧煜明院士、李蘭娟院士、陳曄光院士、陳潤生院士、詹啟敏院士、王小凡院士、約翰·梅卡拉諾斯院士、許田教授、余棣華教授、康毅濱教授、鄭永齊教授,以及澳大講座教授王一濤、湯子康及鄧初夏。

澳大副校長葛偉致辭時表示,澳大不斷提升師資及教研水平,在拓展區域和國際合作、科研創新與產學研發展等方面取得顯著成效,國際聲譽不斷提升,在2024年度泰晤士高等教育世界大學排名中,澳大首次躋身世界前二百強,並有12學科領域進入基本科學指標資料庫(ESI)前1%之列,成績令人鼓舞。

澳大健康科學學院院長兼國家教育部澳門大學精準腫瘤學前沿科學中心首席科學家鄧初夏從建設背景、核心研究方向、代表性學術成果、科研隊伍建設、人才培養等方面全面彙報了中心已取得的進展。他表示,在澳大已有的堅實基礎上,中心團隊針對癌症的發生與發展、腫瘤微環境與免疫調控、癌症轉移及耐藥機制、高效藥物開發及癌症個體化治療等四個方向開展深度研究,利用科研大平台配合研究工作,目標提高癌症早期診斷的準確率,並為癌症患者提供高端化、定制化、個人化的精準醫學預防、診斷及治療可行方案。

在會議總結時,各委員期望前沿科學中心繼續鞏固和加強優勢方向的研究,爭取率先取得前瞻性基礎研究,尤其要加強跨域合作,成立聯合實驗中心,並提升臨床研究實力,與基礎研究相輔相成,激發更多跨領域的研究,納入人工智慧、大數據等其他技術,豐富研究內容。

欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/press-release/detail/57410/


Ministry of Education Frontiers Science Center for Precision Oncology of UM holds its first Academic Committee meeting, academicians and scholars at home and abroad recognise its achievements

The Ministry of Education Frontiers Science Center for Precision Oncology (FSCPO) of the University of Macau (UM) held its first Academic Committee meeting. A number of academicians and research experts from the Chinese Academy of Sciences, the Chinese Academy of Engineering, the US National Academy of Sciences and other prestigious institutions listened to FSCPO’s reports and offered advice to the centre. In addition, during the meeting with UM Rector Yonghua Song, members of the Academic Committee highly praised FSCPO for its outstanding achievements. They emphasised the remarkable and groundbreaking progress the centre has made in cancer research, and its ability to produce high-quality research within just over two years since its establishment.

The conference was held at UM in a hybrid format. Members of the Academic Committee listened to reports on the establishment of research platforms in FSCPO, its operation and management, research output quality, and talent cultivation strategies since its establishment in December 2020. The Academic Committee is made up of Nobel laureate in Chemistry Aaron Ciechanover, Prof Dennis Lo Yuk Ming, Prof Li Lanjuan, Prof Chen Yeguang, Prof Chen Runsheng, Prof Zhan Qimin, Prof Wang Xiao-Fan, Prof John Mekalanos, Prof Xu Tian, Prof Yu Dihua, Prof Kang Yibin, Prof Cheng Yung-Chi, as well as UM Chair Professors Wang Yitao, Tang Zikang, and Chuxia Deng.

In his speech, UM Vice Rector Ge Wei said that UM has continuously improved the quality of its faculty, teaching, and research, resulting in notable achievements in promoting regional and international cooperation, research innovation, and industry-academia collaboration, as well as substantial enhancement of its international reputation. He added that it is encouraging to see UM making its debut among the top 200 universities worldwide in the Times Higher Education World University Rankings 2024. Additionally, 12 subjects offered by the university have entered the top 1 per cent of the Essential Science Indicators (ESI).

Chuxia Deng, dean of UM’s Faculty of Health Sciences and chief scientist of FSCPO, presented a comprehensive report on the progress made by the centre, including the background of its establishment, main research directions, representative academic achievements, formation of the research team, and talent cultivation. He said that on the basis of the solid foundations of UM, FSCPO has carried out in-depth research in four directions, namely the onset and development of cancer, tumour microenvironment and immune regulation, cancer metastasis and drug resistance mechanisms, and efficient drug development and personalised cancer treatment, by making use of the research platforms. The centre aims to improve the accuracy of early diagnosis of cancer and provide cancer patients with high-end, customised, and personalised precision medicine diagnosis, prevention, and treatment options.

During the conclusion section, the Academic Committee members expressed their expectations for FSCPO to continue to strengthen research in areas of advantage. They also emphasised the need to pursue pioneering basic research, particularly through enhanced interdisciplinary collaboration. They also proposed the establishment of joint centres with other institutions and the enhancement of clinical research capabilities to complement basic research, thereby stimulating more interdisciplinary research. Additionally, they suggested incorporating other technologies such as artificial intelligence and big data to enrich the research content.

 

To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/57410/